Beta Bionics, Inc. (BBNX) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US08659B1026
Beta Bionics, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 100.25 m USD |
| Gross profit | 55.54 m USD |
| Operating income | -71.68 m USD |
| EBIT | -84.13 m USD |
| Net income | -73.20 m USD |
| Diluted EPS – continuing operations | -1.81 USD |
Full history since 2022, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Beta Bionics, Inc.
Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes. It offers iLet Bionic Pancreas, an insulin delivery device for the treatment of type 1 diabetes in adults and children six years of age and older. The company is also developing Patch Pump, an insulin pump that is designed to adhere directly to the skin and administer insulin without the need for tubing; Bihormonal iLet, which combines automated delivery of insulin and glucagon; and iLet to treat people with insulin-dependent type-2 diabetes. It has collaboration and license agreement with Xeris Pharmaceuticals, Inc. (Xeris) to develop and commercialize a pump-compatible glucagon formulation; and development and commercialization agreement with Abbott Diabetes Care Inc. to develop and commercialize an automated insulin delivery system. The company was incorporated in 2015 and is headquartered in Irvine, California.
More stocks
- Karnov Group AB (publ) (KAR.ST)
- Nufarm Ltd (NUF.AX)
- Sentia ASA (SNTIA.OL)
- Shandong Golden Empire Precision Machinery Technology Co., Ltd. (603270.SS)
- GRK Infra Oyj (GRK.HE)
- Pantoro Gold Ltd (PNR.AX)
- Taboola.com Ltd. (TBLA)
- Pagegroup PLC (PAGE.L)
- RIAMB (Beijing) Tech Dvlp Co (603082.SS)
- Zhejiang Oceanking Development Co Ltd (603213.SS)
- Henan Jindan Lactic Acid Technology (300829.SZ)
- Jiajiayue Group Co Ltd (603708.SS)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.